Pizzo, Philip A.
Stanford Medicine · Stanford University
11 papers on CoChatORCID 0000-0002-1000-6516
Most cited papers
- Verified
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 1,964
- Verified
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine
Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility
Cited by 859
- Verified
Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection
Berenguer, J., Buck, M., Witebsky, F., Stock, F., Pizzo, P. A., & Walsh, T. J. (1993) · Diagnostic Microbiology and Infectious Disease
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 290
- Verified
Alleviating Suffering 101 — Pain Relief in the United States
Pizzo, P. A., & Clark, N. M. (2012) · New England Journal of Medicine
Pain Management and Opioid UseOpioid Use Disorder Treatment
Cited by 231
- Verified
Pathogenesis of Pulmonary Aspergillosis. Granulocytopenia Versus Cyclosporine and Methylprednisolone-Induced Immunosuppression
Berenguer, J., Allende, M. C., Lee, J. W., Garrett, K., Lyman, C., Ali, N. M., Bacher, J., Pizzo, P. A., & Walsh, T. J. (1995) · American journal of respiratory and critical care medicine
Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune Disorders
Cited by 183
- Verified
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics
Antifungal resistance and susceptibilityPharmaceutical studies and practices
Cited by 120
- Verified
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
Walsh, T. J., Whitcomb, P., Piscitelli, S., Figg, W. D., Hill, S., Chanock, S. J., Jarosinski, P., Gupta, R., & Pizzo, P. A. (1997) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 109
- Verified
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method
Gehrt, A., Peter, J., Pizzo, P. A., & Walsh, T. J. (1995) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 105
- Verified · note
Relieving Pain in America: Insights From an Institute of Medicine Committee
Dzau, V. J., & Pizzo, P. A. (2014) · JAMA
Pain Management and Opioid UseOpioid Use Disorder Treatment
Cited by 84
- Verified
Late Recurrent Candida Endocarditis
Johnston, P. G., Lee, J., Domunski, M., Dressler, F., Tucker, E., Rothenberg, M., Cunnion, R. E., Pizzo, P. A., & Walsh, T. J. (1991) · Chest
Infective Endocarditis Diagnosis and ManagementAntifungal resistance and susceptibility
Cited by 51
- Verified
Amphotericin B in the treatment of Candida cholecystitis
ADAMSON, P. C., RINALDI, M. G., PIZZO, P. A., & WALSH, T. J. (1989) · The Pediatric Infectious Disease Journal
Antifungal resistance and susceptibilityGallbladder and Bile Duct Disorders
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free